Renaissance Capital logo

Altamira Therapeutics (Auris Medical) Priced, Nasdaq: CYTO

Biotech developing treatments for tinnitus and other inner ear disorders.

Industry: Health Care

First Day Return: 0.0%

Biotech developing treatments for tinnitus and other inner ear disorders.
IPO Data
IPO Date 08/05/2014
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $56
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Zug, Switzerland
Founded 2003
Employees at IPO 13
Website www.aurismedical.com

Altamira Therapeutics (Auris Medical) (CYTO) Performance

Created with Highcharts 10.3.2Chart context menuCYTO vs. IPO Index (IPOUSA)20152016201720182019202020212022202320242025-100%0%+ 100%+ 200%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index